BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 15, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sectorBreaking News: Trump administration impacts continue to roil the life sciences sectorBreaking News: Trump administration impacts continue to roil the life sciences sector
Home » Topics » BioWorld MedTech

BioWorld MedTech
BioWorld MedTech RSS Feed RSS

Financings for Sept. 24, 2025

Sep. 24, 2025
Med-tech firms raising money in public or private financings, including: Amplifymd, Leo Cancer Care.
Read More

Other news to note for Sept. 24, 2025

Sep. 24, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Align Technology, Angelalign, Art-Islets, Austrianova, Avant Technologies, Cellcarta, Guardant Health, Lunit, NorthStar Medical, Quest Diagnostics, Terthera.
Read More

Regulatory actions for Sept. 24, 2025

Sep. 24, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Burning Rock, Fluid AI, Neuromod Devices, TSC Life.
Read More
Heartflow illustration

FDA clears Heartflow’s next-gen plaque analysis

Sep. 23, 2025
By Annette Boyle
Heartflow Inc. hasn’t skipped a beat in pumping out good news, with U.S. FDA 510(k) clearance for its next-gen plaque analysis algorithm and platform and Cigna coverage across all lines of coverage starting in October. The new algorithm improves plaque detection 21% compared to the first version of Heartflow’s algorithm.
Read More
Red arrow pointing downward on a stock market ticker

Funding crisis looms for European med tech

Sep. 23, 2025
By Shani Alexander
The lack of funding available for early-stage European med-tech and AI-based companies could soon see many go under as their current backers run out of capital, and new investors fail to materialize, Hubert Birner, managing partner at TVM Capital Life Science, told BioWorld.
Read More

Appointments and advancements for Sept. 23, 2025

Sep. 23, 2025
New hires and promotions in the med-tech industry, including: Bridge to Life, Healthtrackrx, Inventus Group.
Read More

Financings for Sept. 23, 2025

Sep. 23, 2025
Med-tech firms raising money in public or private financings, including: Caregility, Pictor.
Read More

In the clinic for Sept. 23, 2025

Sep. 23, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ultromics.
Read More

Other news to note for Sept. 23, 2025

Sep. 23, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Bracken, Caristo Diagnostics, Compass Bioinformatics, Epic, Genomenon, Labconnect, Myriad, Quest, Sophia Genetics.
Read More

Regulatory actions for Sept. 23, 2025

Sep. 23, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bunkerhill Health, Cionic, Heartflow, Noul.
Read More
Previous 1 2 … 50 51 52 53 54 55 56 57 58 … 10203 10204 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 12, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 12, 2025.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • Illustration of head with maze that is missing parts

    CTAD 2025: The challenges of combination therapies for dementia

    BioWorld Science
    At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing